High-resolution Intra-operative PSMA PET-CT in Prostate Cancer
NCT: NCT06298838 · NOT_YET_RECRUITING
Brief Summary
This is a Single-center, diagnostic open-label prospective, pilot study in a total of 10 patients affected by Prostate cancer (PCa) with a risk of lymph node invasion (LNI) higher than 5% and candidates for a robot-assisted radical prostatectomy (RARP) with an extended pelvic lymph node dissection (ePLND) . The aim of the trial is to evaluate the feasibility and accuracy and clinical value of a novel high-resolution perioperative PET-CT-scan for intraoperative margin and lymph node invasion assessment, after 18F-PSMA injection, using histopathology as the gold standard.
Frequently Asked Questions
What is High-resolution Intra-operative PSMA PET-CT in Prostate Cancer?
High-resolution Intra-operative PSMA PET-CT in Prostate Cancer is a clinical trial registered under NCT06298838. Current status: NOT_YET_RECRUITING.
What is the status of NCT06298838?
The current status of NCT06298838 (High-resolution Intra-operative PSMA PET-CT in Prostate Cancer) is: NOT_YET_RECRUITING.
When did High-resolution Intra-operative PSMA PET-CT in Prostate Cancer start?
High-resolution Intra-operative PSMA PET-CT in Prostate Cancer started on 2026-06.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.